Søren Lemonius
Chief Financial Officer
Biomedical Sciences
Galecto Biotech
Denmark
Biography
Søren Lemonius partner at Sunstone Capital and has previously spent 10+ years in corporate management. During five years as CTO at Danionics, He participated in developing the company from a 30 employee technology company to a €27+ million, 300+ employees, product selling, listed company. He was responsible for releasing three new product generations. Before joining Danionics, Mr. Lemonius was Innovation Manager at FOSS Analytical, a private, €130+ million developer and producer of analytical equipment. Søren established and developed FOSS’s Innovation Center as a “First Responder†to new project and product opportunities. Søren also serves on the board of Atonomics A/S, Biomonitor A/S, TD Vaccine A/S and Nuevolution A/S. Carsten Schou, PhD
Research Interest
Biomedical Sciences
